search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Antimicrobial resistance


This is not to say that every bacterium causing an infection like a UTI become resistant, or that every infection becomes sepsis. It is to recognise that the decisions made at the beginning of a common infection can influence what happens next. If we want better prescribing, we need better diagnosis. For UTIs, that means improving how midstream samples are collected to meet guideline recommendations, developing reliable diagnostic tools that identify infection more effectively, and getting meaningful information about the bacteria involved and which treatments are likely to be effective, sooner. Diagnosis is only one part of the pathway.


We also need a clinical pathway that makes the right response easier to deliver when a patient deteriorates.


Sepsis Six That is something I have spent much of my career building. When we developed the Sepsis Six at the UK Sepsis Trust, we wanted to give clinicians a simple set of six actions to take promptly when a patient with suspected sepsis is deteriorating. It was built on a simple idea: when a patient’s condition is deteriorating, the essential actions should be clear, structured and reliable, not left to chance. The lesson behind this tool is bigger than the six actions themselves. When someone is becoming seriously ill, a good clinical pathway should help clinicians recognise what is


happening, know what needs to be done and act without unnecessary delay. That starts at the very beginning of the pathway: with the symptoms a patient describes, the way a midstream sample is collected, the test that is chosen, and the information available to the clinician when they decide treatment. This is why the timing of Infection Prevention


Week and World AMR Awareness Week matters. They remind us that these two conversations cannot be kept apart - and neither can the clinical pathway that runs from the first symptoms to diagnosis and treatment. If we want to improve outcomes at the end of that


Getting the diagnosis right will not solve sepsis. It will not solve antimicrobial resistance. But it can help us break the cycle earlier, before an infection becomes harder to treat


About the author


Dr. Ron Daniels BEM is the Founder and Chief Executive of the UK Sepsis Trust and Vice President of the Global Sepsis Alliance. He is a successful medical innovator and leader with particular experience in translational impact. He advises on clinical applications, systems integration and translational medicine in the fields of severe infection, antimicrobial stewardship, sepsis, and the deteriorating patient. Dr. Daniels also co-developed the Sepsis Six treatment bundle, in use in most British hospitals (and saving lives in 28 other countries around the world), and co-developed the Red Flag Sepsis recognition tool, endorsed by NICE in 2019.


November 2026 I www.clinicalservicesjournal.com 33


pathway, we must improve what happens right at the beginning.


Getting the diagnosis right will not solve sepsis. It will not solve antimicrobial resistance. But it can help us break the cycle earlier, before an infection becomes harder to treat, before antibiotic options become more limited, and before a serious infection has the chance to become life-threatening. To find out more, visit: https://sepsistrust.org/


CSJ


eddows - stock.adobe.com


Dr_Microbe - stock.adobe.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71